Emergent Europe

Emergent BioSolutions is a global life sciences company dedicated to providing preparedness and response solutions for public health threats, including biological, chemical, and opioid-related crises. The company's commercial portfolio features high-profile products such as Narcan (naloxone HCl) Nasal Spray for opioid overdose reversal and BioThrax, the only FDA-licensed vaccine for anthrax prevention. Emergent also operates as a significant Contract Development and Manufacturing Organization (CDMO), offering specialized services in biologics and vaccine production for government and commercial clients. With a history of strategic acquisitions in Europe, including the UK-based Microscience, the company maintains a global footprint to support international health security and medical countermeasure stockpiling. Its European operations, often referred to as Emergent Europe, focus on research, development, and the commercialization of specialty products across the region.